Last Updated on September 24, 2021 by The Health Master
All Indian children aged 12 or older will become eligible for C-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the matter told Reuters.
The world’s first DNA-based C-19 vaccine, ZyCoV-D won emergency authorisation from Indian regulators last month. From October, the company, better known as Zydus Cadila, will produce 10 million doses a month.
The vaccine is the only one approved for children in India, which has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.
ZyCoV-D is a three-dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.
It is a needle-free vaccine administered using The Pharma Jet, a needle free applicator – ‘Tropis’, which ensures painless intradermal vaccine delivery.
Last month, the government’s Department of Biotechnology (DBT) said that the “plug-and-play” technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.
For informative videos by The Health Master, click on the below YouTube icon: